Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma
The objective of the present study was to evaluate the efficacy and safety of regorafenib in comparison with dinutuximab with chemotherapy in Chinese children with advanced neuroblastoma. The patients aged less than 16 years who were histologically diagnosed with advanced neuroblastoma were enrolled...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bangladesh Pharmacological Society
2019-02-01
|
| Edice: | Bangladesh Journal of Pharmacology |
| Témata: | |
| On-line přístup: | https://www.bjp.asia/index.php/bjp/article/view/8 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|